Inhibition of drug-resistant mutants of ABL, KIT, and EGF receptor kinases.

Carter TA, Wodicka LM, Shah NP, Velasco AM, Fabian MA, Treiber DK, Milanov ZV, Atteridge CE, Biggs WH, Edeen PT, Floyd M, Ford JM, Grotzfeld RM, Herrgard S, Insko DE, Mehta SA, Patel HK, Pao W, Sawyers CL, Varmus H, Zarrinkar PP, Lockhart DJ
Proc Natl Acad Sci U S A. 2005 102 (31): 11011-6

PMID: 16046538 · PMCID: PMC1180625 · DOI:10.1073/pnas.0504952102

MeSH Terms (20)

Aminoquinolines Aniline Compounds Cell Line Drug Resistance, Neoplasm ErbB Receptors Humans Indoles Kinetics Morpholines Mutation Naphthalenes Neoplasms Oncogene Proteins v-abl Organic Chemicals Piperazines Protein Kinase Inhibitors Proto-Oncogene Proteins c-kit Pyrazoles Pyrroles Sunitinib

Connections (1)

This publication is referenced by other Labnodes entities: